德克斯特兰-40减少部分片失效:自由片后抗血栓药物的系统审查和元分析
Yi-En Lin1, Mei-Chun Chen2,3
1From Taipei Veterans General Hospital, Taipei, Taiwan.
Plastic and reconstructive surgery. Global open
|May 16, 2024
概括
手术后使用的抗血栓剂不会防止片失效或血栓形成,但会增加出血风险. 德克斯-40可能会减少部分片的故障,但会带来风险. 需要进一步的研究.
科学领域:
- 整形外科 整形外科 整形外科
- 血管外科 血管外科
- 血栓形成研究研究
背景情况:
- 抗血栓剂通常用于自由手术后的手术,以预防并发症.
- 在这种情况下,关于它们的有效性和安全性的证据是不一致的.
- 进行了一项元分析,以澄清这些药物的作用.
研究的目的:
- 评估术后抗血栓剂在减少片失效和血栓形成方面的有效性.
- 评估抗血栓剂对出血和血瘤形成的影响.
- 调查抗血小板剂,抗凝固剂和德克斯-40的特定作用.
主要方法:
- 在PubMed,Cochrane和ClinicalTrials.gov.gov进行了系统的文献搜索.
- 包括比较使用和不使用抗血栓剂的自由手术结果的研究.
- 主要结局是完全片失败;次要结局包括部分片失败,脚血栓,和出血/血瘤.
主要成果:
- 抗血栓剂并没有显著减少片衰竭或足骨血栓形成.
- 在使用抗血栓剂时,观察到出血和血液瘤风险显著增加 (RR, 1.535).
- 德克斯-40与部分片衰竭的减少有关 (RR,0.535),但增加了出血风险.
结论:
- 手术后的抗血栓剂,抗血小板剂和抗凝剂不会改善片存活率或预防血栓形成,但会增加出血并发症.
- 德克斯特兰-40可能会减少部分片失效,尽管由于潜在的肺部应急症,其使用是谨慎的.
- 需要进一步的前性研究才能充分了解对血栓形成和片结局的影响.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:30Drug Binding to Blood Components
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...